TruWealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33M Buy
35,900
+526
+1% +$533K 1.59% 21
2025
Q4
$38M Buy
35,374
+476
+1% +$455K 1.86% 13
2025
Q3
$26.6M Buy
34,898
+1,437
+4% +$1.07M 1.35% 20
2025
Q2
$26.1M Buy
33,461
+1,379
+4% +$1.07M 1.44% 21
2025
Q1
$26.5M Buy
32,082
+851
+3% +$708K 1.6% 19
2024
Q4
$24.1M Sell
31,231
-1,645
-5% -$1.36M 1.45% 22
2024
Q3
$29.1M Sell
32,876
-220
-0.7% -$198K 1.78% 17
2024
Q2
$30M Sell
33,096
-260
-0.8% -$208K 1.99% 16
2024
Q1
$25.9M Buy
33,356
+521
+2% +$371K 1.81% 19
2023
Q4
$19.1M Sell
32,835
-5,703
-15% -$3.33M 1.46% 22
2023
Q3
$20.7M Buy
38,538
+387
+1% +$199K 1.78% 20
2023
Q2
$17.9M Buy
38,151
+11,851
+45% +$4.97M 1.54% 23
2023
Q1
$9.03M Buy
26,300
+14,013
+114% +$4.73M 0.83% 35
2022
Q4
$4.5M Buy
12,287
+11,561
+1,592% +$4.1M 0.44% 50
2022
Q3
$235K Buy
726
+76
+12% +$24.1K 0.02% 118
2022
Q2
$211K Buy
+650
New +$195K 0.02% 129

Other funds holding LLY

TruWealth Advisors's LLY Position: Q1 2026 in Review

TruWealth Advisors increased its Eli Lilly (LLY) stake by 1.5% in Q1 2026, buying an estimated $533K and bringing the position to 35,900 shares worth $33M. The position accounts for 1.59% of the portfolio, ranked #21.

TruWealth Advisors first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $38M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • TruWealth Advisors held 35,900 shares of Eli Lilly worth $33M as of Q1 2026.
  • TruWealth Advisors bought 526 Eli Lilly shares in Q1 2026, an estimated $533K.
  • Eli Lilly made up 1.59% of TruWealth Advisors's portfolio in Q1 2026, its #21 holding.
  • TruWealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
  • TruWealth Advisors's Eli Lilly position peaked at $38M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on TruWealth Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.